Second-line chemotherapy for patients with oesophagogastric adenocarcinoma

Se Hoon Park

doi:10.1016/S1470-2045(13)70580-1

Second-line chemotherapy for patients with oesophagogastric adenocarcinoma

Se Hoon Park

Department of Internal Medicine

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	8-10
Number of pages	3
Journal	The Lancet Oncology
Volume	15
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(13)70580-1
State	Published - Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1470-2045(13)70580-1

Cite this

@article{3f23c586d4c540d6a887ea8a0e5c2c4a,

title = "Second-line chemotherapy for patients with oesophagogastric adenocarcinoma",

author = "Park, \{Se Hoon\}",

year = "2014",

month = jan,

doi = "10.1016/S1470-2045(13)70580-1",

language = "English",

volume = "15",

pages = "8--10",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "1",

}

TY - JOUR

T1 - Second-line chemotherapy for patients with oesophagogastric adenocarcinoma

AU - Park, Se Hoon

PY - 2014/1

Y1 - 2014/1

UR - https://www.scopus.com/pages/publications/84891372019

U2 - 10.1016/S1470-2045(13)70580-1

DO - 10.1016/S1470-2045(13)70580-1

M3 - Letter

AN - SCOPUS:84891372019

SN - 1470-2045

VL - 15

SP - 8

EP - 10

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 1

ER -

Second-line chemotherapy for patients with oesophagogastric adenocarcinoma

UN SDGs

Access to Document

Other files and links

Cite this